Difference between revisions of "Transmission routes"
m |
(→What is already known) |
||
| Line 2: | Line 2: | ||
=What is already known= | =What is already known= | ||
| + | * Person to Person Transmission (close contact). <Ref name="Rothan2020">Rothan, Hussin A., and Siddappa N. Byrareddy. "The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak." Journal of Autoimmunity (2020): 102433.</ref> | ||
| + | ** Droplet infection | ||
| + | ** Cross contamination of hands | ||
| + | * No evidence of vertical (mother-child) transmission. <Ref name="Rothan2020"/> | ||
| + | * Potential of SARS-CoV2 to survive in aerosol. <Ref name="Doremalen2020">van Doremalen, Neeltje, et al. "Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1." medRxiv (2020).</ref> | ||
=Topic 1= | =Topic 1= | ||
Revision as of 08:36, 18 March 2020
This page collects observations, interpretations, and consequences for action about Transmission Routes of SARS-CoV2. Please observe the structure of the page, when you add your content. Please use references where possible. Remember to find the relevant page. For example, if your observation is about Sources, please use that page, instead of posting your content here.
Contents
What is already known
- Person to Person Transmission (close contact). [1]
- Droplet infection
- Cross contamination of hands
- No evidence of vertical (mother-child) transmission. [1]
- Potential of SARS-CoV2 to survive in aerosol. [2]
Topic 1
Observations
Analysis and interpretation
Consequences for action
References
- ↑ 1.0 1.1 Rothan, Hussin A., and Siddappa N. Byrareddy. "The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak." Journal of Autoimmunity (2020): 102433.
- ↑ van Doremalen, Neeltje, et al. "Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1." medRxiv (2020).
